about
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionBiomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomicsBeta-Band Functional Connectivity is Reorganized in Mild Cognitive Impairment after Combined Computerized Physical and Cognitive TrainingFunctional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease riskLifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy agingThe Alzheimer's disease neuroimaging initiative: progress report and future plans2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease.Physical activity and brain function in older adults at increased risk for Alzheimer's diseaseNovel CSF biomarkers for Alzheimer's disease and mild cognitive impairmentBiomarkers for cognitive impairment in Parkinson disease.Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictorsSubtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scansBiomarker discovery in neurodegenerative diseases: a proteomic approach.Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometryNeuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states.Relative contributions of biomarkers in Alzheimer's diseaseCortical signatures of cognition and their relationship to Alzheimer's disease.Interactive effects of physical activity and APOE-ε4 on white matter tract diffusivity in healthy elders.Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease.Olfactory functions scale with circuit restoration in a rapidly reversible Alzheimer's disease model.Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopyMRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.Impaired default network functional connectivity in autosomal dominant Alzheimer disease.Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Relationship between changes in brain MRI and (1)H-MRS, severity of chronic liver damage, and recovery after liver transplantation.Biomarkers of Alzheimer's disease in body fluids.Tau and p-tau as CSF biomarkers in dementia: a meta-analysis.Amyloid imaging.The prognostic value of amyloid imaging.CSF Biomarkers for Alzheimer's Disease Diagnosis.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.An image processing technique for diagnosis of Alzheimer's disease.Biomarkers for the identification and treatment of dementia.CSF biomarkers in different phenotypes of Parkinson disease.Hippocampal atrophy in people with memory deficits: results from the population-based IPREA study.
P2860
Q27006831-07128C9E-63BF-4E49-9ADA-293B50D54B77Q27024518-AB80101D-D920-411C-B7B9-B89FE94B3BE6Q27313345-0FEF40F5-03A6-4C97-9CFA-3E6D4732250EQ28394799-08D31778-D017-47B9-891C-D350FE613DEEQ28395012-D4F40858-1F9A-49B1-AF67-D972E0692F0AQ28749585-3525FCF6-5B39-45C0-BCEF-82EE862EE9F2Q30971403-B3877BB7-9459-49E8-BEB1-AB8923EE2617Q33571865-52F64216-4C96-42C2-A72B-D79D7A1DDA7EQ33772053-033B559B-C363-4D6B-BFA4-97F32458FB1CQ33894316-3B0805D1-E2FF-48EF-91FC-F058BA42484AQ33896664-63EE7A73-033C-4E43-9EC0-4A892A9E801FQ33981434-62336CAD-ED8D-43A1-9E6D-735471723A2EQ33987715-E6A1FC4D-FAF5-4129-94F4-369BB261973EQ34065449-FFE08F57-A2EF-40B6-9703-7B43DB018F6FQ34081087-64CB4F57-CAD7-4884-82F0-AED69450D94EQ34125681-07E81BAF-4224-49C8-BF67-AE83DE5E93B1Q34157882-C9ADDBD5-988F-4C13-AD46-354482057159Q35512038-14E8E45C-07D3-418D-AD1C-C5E20C552C39Q36435826-C8E1FCFB-05EC-4084-9756-10036766FCF9Q36558019-990E9CA9-148A-419C-B25A-D0A0FEE59731Q36558527-EE083507-8B47-4EF4-8DA6-A45A93EF5708Q36865597-AC084108-3990-4229-897D-7DEB0C03D86DQ37041542-1F67898B-3F08-4541-B456-05BFD3D56E66Q37073878-4D5448A3-ADF1-4E42-A9E0-37B2260FF396Q37158181-D18CD763-7D14-4627-A3A8-BA7C08294340Q37180917-102816A0-65DC-427D-9265-66A185C374AAQ37227424-A7E28106-ECC8-4F51-AC0C-A5BE8057B5B8Q37358672-A2AF3956-4257-47EB-9A17-455B0F5D5463Q37733519-13749D9B-237B-4278-85E1-1BFCC9D6562BQ37769463-4540D48B-9F6C-41E8-93ED-500C5BA110C1Q37845820-081284A5-8D8A-4932-8902-3BADFDCC12BFQ37897691-6BBDC407-0C5E-4FF1-BC48-E6E50F40B9D1Q38001577-0756F559-B132-4078-8995-0C8FE1E6765FQ41897818-5B92158D-C747-4E7F-BB60-1804AC23D297Q42126269-36418A06-8613-4A48-B7D9-19804965055BQ42730340-DC707BDD-B302-47BA-B8BE-1240097F2A0CQ43064418-B9121369-542E-43CF-B482-3A2B04F81E8FQ45753674-C27598C0-CF02-4BB5-A886-8022493B5480Q50860815-5184822D-DD33-4B7C-B8B3-CD86CC0CDE03
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Biomarkers for early detection of Alzheimer pathology.
@ast
Biomarkers for early detection of Alzheimer pathology.
@en
type
label
Biomarkers for early detection of Alzheimer pathology.
@ast
Biomarkers for early detection of Alzheimer pathology.
@en
prefLabel
Biomarkers for early detection of Alzheimer pathology.
@ast
Biomarkers for early detection of Alzheimer pathology.
@en
P2093
P2860
P921
P356
P1433
P1476
Biomarkers for early detection of Alzheimer pathology.
@en
P2093
A Borthakur
J Q Trojanowski
P2860
P356
10.1159/000109754
P577
2007-12-05T00:00:00Z